Cinnarizine Sopharma

Indication:
Supportive treatment for symptoms of labyrinthine disorders including dizziness, nausea, vomiting, tinnitus and nystagmus.
Prevention of motion sickness.
Migraine prevention.
Supportive treatment for symptoms of cerebrovascular origin including dizziness, ringing in the ears (tinnitus), vascular headache, irritability, memory loss and inability to concentrate.
Supportive treatment for symptoms of peripheral vascular disorders, including Raynaud’s disease, acrocyanosis, intermittent claudication, trophic disorders and varicose ulcers, paresthesia, nocturnal limb cramps, coldness of the limbs.

50 tablets

25 mg